Curative Health Services, Inc., incorporated in 1984, delivers care and clinical outcomes for patients experiencing serious acute or chronic medical conditions. The Company's Specialty Infusion business unit provides intravenous and injectable biopharmaceutical and compounded pharmaceutical products and infusion services to patients with chronic and critical disease states. The Wound Care Management business unit is a provider of wound care services specializing in chronic wound care management. It manages, on behalf of hospital clients, a nationwide network of Wound Care Center programs that offer a range of services for treatment of chronic wounds. On March 27, 2006, the Company and each of its direct and indirect subsidiaries filed voluntary petitions in the United States Bankruptcy Court for the southern district of New York. On December 2, 2005, the Company sold certain personal property, licenses, permits, contracts, leases and patient files related to its specialty injectable and oral medications business, including Synagis to ProCare Pharmacy Inc. and ProCare Pharmacy Direct, Inc. (collectively, ProCare). Specialty Infusion The Specialty Infusion business unit provides injectable or infusible biopharmaceutical and compounded pharmaceutical products to patients with chronic health conditions, for which there is no known cure and to patients with critical disease states that require specialized expertise in high-touch injectable and infusion therapies. High touch therapies require clinical management, special product handling and specialized nursing administration. The Specialty Infusion business unit focuses on several therapies, including hemophilia clotting factor, anti-infective therapy, intravenous immune globulins (IVIG) and total parenteral nutrition (TPN). These products are used by patients with chronic or severe conditions, such as hemophilia, respiratory syncytial virus (RSV), immune system disorders, chronic or severe infections, nutritionally compromised and other severe conditions requiring nutritional support, cancer, rheumatoid arthritis, hepatitis C and multiple sclerosis. All patient care is delivered through a national footprint of community-based branches. Each local branch has an experienced multidisciplinary team of pharmacists, nurses, reimbursement specialists and patient service representatives who manage all aspects of a patient's infusion and related support needs. The Company purchases biopharmaceutical and other pharmaceutical products from suppliers and contracts with insurance companies and other payers to provide its services, which include coordination of patient care, 24-hour nursing and pharmacy availability, patient education and reimbursement billing and collection services. As of December 31, 2005, the Company had approximately 485 payer contracts and provided products or services in approximately 45 states. Wound Care Management The Wound Management Program consists of diagnostic and therapeutic treatment procedures that are designed to meet each patient's specific wound care needs. The Company's treatment procedures are designed to achieve results for wound healing based on significant experience in the field. In most cases, patients arriving at a Wound Care Center program have been treated with traditional wound healing techniques, but continue to suffer from chronic wounds. Upon the commencement of treatment under the Wound Management Program, medical personnel conduct a systematic diagnostic assessment of the patient. Specialized treatment plans are then established for the patient, based on the underlying cause of the wound and the status of the patient. After the assessment phase, the course of treatment in the Wound Management Program may include revascularization, infection control, wound debridement, skin grafting, nutrition, protection devices, patient education, referrals and effective management of care through patient/provider communications. To measure the effectiveness of the Wound Management Program, the Company has developed a functional
As Of: 12/31 16:00 ET
*Quotes delayed by 20min.
BuyIns.Net Alerts for Symbol CUREQ
- No BuyIns.Net Alerts Available for CUREQ
Graphs for CUREQ
3 Month Graph
6 Month Graph
1 Year Graph
